- Home >
- Publications >
- Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles
Identification of MRC2 and CD209 receptors as targets for photodynamic therapy of retinoblastoma using mesoporous silica nanoparticles
Authors
A. Gallud, D. Warther, M. Maynadier, M. Sefta, F. Poyer, C. D. Thomas, C. Rouxel, O. Mongin, M. Blanchard-Desce, A. Morère, L. Raehm, P. Maillard, J. O. Durand, M. Garcia, M. Gary-Bobo
Abstract
An overexpression of MRC2 and CD209 mannose receptors was revealed in retinoblastoma and antibodies against these receptors were grafted to multifunctional nanoparticles for targeting of imaging and photodynamic therapy.
